Animal scale-up
The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Wajima et al. [63] developed a method for predicting human plasma concentration–time profiles from animal data, building on the earlier Dedrick plot approach [13] but with enhanced flexibility.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [13]
Citations
Cites
Crank, J. (1956) · CERN Document Server (European Organization for Nuclear Research) · Cited by 18,978
Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., & Skipper, H. E. (1966) · PubMed · Cited by 1,382
Ni, W.-M. (2011) · Society for Industrial and Applied Mathematics eBooks · doi:10.1137/1.9781611971972 · Cited by 1,064
Biopharmaceutics and Relevant Pharmacokinetics
Wagne, J. G. (1970) · Drug Information Bulletin · doi:10.1177/009286157000400250 · Cited by 616
ADVANCES IN CHEMISTRY SERIES No. 106
(1972) · Analytical Chemistry · doi:10.1021/ac60318a838 · Cited by 513
Quantitative Relations in the Physiological Constitutions of Mammals
Adolph, E. F. (1949) · Science · doi:10.1126/science.109.2841.579 · Cited by 500 · cited 2×
“Inulin clearance 0.77 PAH clearance 0.80 Basal 0 2 consumption 0.734 Endogenous N output 0.72 O 2 consumption by liver slices 0.77 Kidneys weight 0.85 Heart weight 0.98 Liver weight 0.87 Stomach and intestines weight 0.94 Blood weight 0.99 "Abstracted from Adolph ( 23 ).”
BackgroundInfluentialBischoff, K. B., Dedrick, R. L., Zaharko, D. S., & Longstreth, J. A. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600803 · Cited by 480
Self-citationStudies of the enzymatic deamination of cytosine arabinoside—I
Camiener, G. W., & Smith, C. G. (1965) · Biochemical Pharmacology · doi:10.1016/0006-2952(65)90175-9 · Cited by 292
Brodie, B. B., Kurz, H., & Schanker, L. S. (1960) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25859-1 · Cited by 279
Brodie, B. B., Kurz, H., & Schanker, L. S. (1960) · PubMed · Cited by 255
Research works printed but not linked: 3
- K. B. Bischoff and R. G. Brown. Drug distribution in mammals.Chem. Eng. Prog. Symp. Ser. No. 66 62: 33–45(1966).
- K. B. Bischoff, K. J. Himmelstein, R. L. Dedrick, and D. S. Zaharko. InAdvances in Chemistry Series No. 118, American Chemical Society, Washington, D.C., 1973, pp. 47–64.
- R. L. Dedrick, P. Vantoch, E. A. Gombos, and R. Moore. Kinetics of activated carbon kidney.Trans. Am. Soc. Artif. Int. Organs 13: 236–242 (1967).
Cited by
Items 201–300 of 398
Pasquiers, B., Benamara, S., Felices, M., Nguyen, L., & Declèves, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112754 · Cited by 23
“- as for the allometric scaling, the concentrations are correlated to the body weight; - and time equivalency between two species is also correlated to the body weight [54].”
BackgroundMandikian, D., Figueroa, I., Oldendorp, A., Rafidi, H., Ulufatu, S., Schweiger, M. G., Couch, J. A., Dybdal, N., Joseph, S., Prabhu, S., et al. (2018) · AAPS Journal · doi:10.1208/s12248-018-0264-z · Cited by 25
Hissink, A. M., van Ommen, B., Krüse, J., & van BLADEREN, P. J. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8184 · Cited by 23
Bae, S. K., Lee, S. J., Kim, Y. G., Kim, S. H., Kim, J. W., Kim, T., & Lee, M. G. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.437 · Cited by 22
“Interspecies scaling of Cl of drugs appeared to be relatively successful for the drugs which are mainly excreted via the kidney (a physical process) [40,41].”
BackgroundShafiee, A., McIntire, G. L., Sidebotham, L. C., & Ward, K. W. (2008) · Veterinary Ophthalmology · doi:10.1111/j.1463-5224.2008.00619.x · Cited by 22
Ait‐Oudhia, S., Scherrmann, J., & Krzyżański, W. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167304 · Cited by 25
“The extrapolation from rats to humans using allometric principles (Dedrick, 1973) for volume, clearance, and lifespan parameters has been successfully applied for rHuEPO (Mager et al., 2009).”
MethodImplications of Pharmacokinetic Modeling in Risk Assessment Analysis
Lutz, R. J., & Dedrick, R. L. (1987) · Environmental Health Perspectives · doi:10.1289/ehp.877697 · Cited by 22
Self-citationInterspecies Scaling of Risk for Radiation-induced Bone Cancer
Raabe, O. G., Rosenblatt, L. S., & Schlenker, R. A. (1990) · International Journal of Radiation Biology · doi:10.1080/09553009014551151 · Cited by 21
Physiologic Pharmacokinetic Modeling
Colburn, W. A. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03199.x · Cited by 21
ZIV, G., van Creveld, C., Ben‐Zvi, Z., Glickman, A., & Yagil, R. (1995) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.1995.tb00594.x · Cited by 21
Wyska, E. (2010) · Pharmacology · doi:10.1159/000288734 · Cited by 20
Shibayama, T., Matsushita, Y., Kurihara, A., Hirota, T., & Ikeda, T. (2006) · Xenobiotica · doi:10.3109/00498250601047889 · Cited by 20
Yamamoto, T., Itoga, H., Kohno, Y., Nagata, K., & Yamazoe, Y. (2005) · Xenobiotica · doi:10.1080/00498250500159371 · Cited by 22
Dalley, J. W., Gupta, P., & Hung, C. T. (1990) · Toxicology Letters · doi:10.1016/0378-4274(90)90027-j · Cited by 20
Assael, B. M., Bánfi, G., Appiani, A. C., Edefonti, A., & Jusko, W. J. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00605993 · Cited by 20
“The shorter t,~ values in the younger subjects are consistent with pharmacokinetic expectations, as scale-up principles indicate that larger species or persons should have longer t,~'s [12].”
ResultThakore, K. N. (1991) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(91)90014-6 · Cited by 20
Sawada, Y., Harashima, H., Hanano, M., Sugiyama, Y., & Iga, T. (1985) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.8.757 · Cited by 20
Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2
Sharma, A., Benbrook, D. M., & Woo, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194046 · Cited by 19
Pharmacokinetic modeling in toxicology: a critical perspective
Wen, Y. H., Kalff, J., & Peters, R. H. (1999) · Environmental Reviews · doi:10.1139/a99-003 · Cited by 19
Carbon, C., Dromer, F., Brion, N., Crémieux, A., & Contrepois, A. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.3.373 · Cited by 19
Dose-Dependent Protein Binding and Disposition of Prednisolone in Rabbits
Rocci, M. L., & Jusko, W. J. (1981) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600701105 · Cited by 19
Melhem, M. R. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.199794 · Cited by 20
“In general, the common practice uses allometric scaling principles to extrapolate compartmental PK properties from animals to humans (Dedrick, 1973).”
BackgroundModern Drug Discovery and Development
Salazar, D. E., & Gormley, G. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802101-9.00041-7 · Cited by 20
Furukawa, T. Y., Nakamori, F., Tetsuka, K., Naritomi, Y., Moriguchi, H., Yamano, K., Terashita, S., & Teramura, T. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-088 · Cited by 18
Liu, D., Song, H., Song, L., Liu, Y., Cao, Y., Jiang, J., & Hu, P. (2016) · Xenobiotica · doi:10.1080/00498254.2016.1205761 · Cited by 19
“…is that mammals have similar anatomy, physiology, biochemistry and cellular structure across species, which allows interspecies scaling of physiological variable (such as blood flow, heart rate and organ size) or basal metabolic rate (Anderson & Holford, 2008; Dedrick, 1973; Gillooly et al., 2001).”
BackgroundInterspecies scaling: predicting clearance of anticancer drugs in humans
Mahmood, I. (1996) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189726 · Cited by 18
Sugita, O., Sawada, Y., Sugiyama, Y., Iga, T., & Hanano, M. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600730513 · Cited by 18
Andersen, M. E., Mallick, P., M.A., H. J. C. I., Yoon, M., Olsen, G. W., & Longnecker, M. P. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111183 · Cited by 17
Pharmacokinetics and Pharmacodynamics of Peptide and Protein Therapeutics
Meibohm, B. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6486-0_5 · Cited by 18
Monoclonal Antibodies: From Structure to Therapeutic Application
Davis, J. D., Deng, R., Boswell, C. A., Zhang, Y., Li, J., Fielder, P. J., Joshi, A., & Kenkare-Mitra, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6486-0_7 · Cited by 21
Chemotherapy Dose Calculation and Administration in Exotic Animal Species
HAHN, K. (2005) · Seminars in Avian and Exotic Pet Medicine · doi:10.1053/j.saep.2005.06.004 · Cited by 17
Shim, H. J., Kim, Y. C., Lee, J. H., Kwon, J. W., Kim, W. B., Kim, Y. G., Kim, S. H., & Lee, M. G. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.455 · Cited by 17
“However, scaling of the Cl among species was less successful if drug metabolism was the primary route for elimination (as a chemical process) [26,29].”
BackgroundVariation in plasma halflife of gentamicin between species in relation to bodyweight and taxonomy
KIRKWOOD, J. K., & MERRIAM, J. (1990) · Research in Veterinary Science · doi:10.1016/s0034-5288(18)31070-1 · Cited by 17
Simulations of methylene chloride pharmacokinetics using a physiologically based model
Angelo, M. J., & Pritchard, A. B. (1984) · Regulatory Toxicology and Pharmacology · doi:10.1016/0273-2300(84)90043-6 · Cited by 17
Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling
Yang, R. S. H., Dennison, J. E., Andersen, M. E., Ou, Y. C., Liao, K. H., & Reisfeld, B. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc023 · Cited by 17
“Two timeless publications by these investigators are, respectively, “Drug Distribution in Mammals” (Bischoff and Brown, 1966) and “Animal Scale-Up” (Dedrick, 1973); these articles are highly recommended to those who are interested in PBPK modeling.”
BackgroundJi, H. Y., Shin, B. S., Jeong, D. W., Park, E. J., Park, E., Yoo, S. D., & Lee, H. S. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1230-1 · Cited by 17
Dallas, C. E., Chen, X. M., Muralidhara, S., Varkonyi, P., Tackett, R. L., & Bruckner, J. V. (1995) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399509531961 · Cited by 16
Nonlinearities in amoxycillin pharmacokinetics I. Disposition studies in the rat
Torres‐Molina, F., Peris, J., Garcia-Carbonell, M. C., Aristorena, J. C., Granero, L. M., & Pla-Delfina, J. M. (1992) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510130103 · Cited by 16
M.A., H. J. C. I., & Fuchsman, P. C. (2023) · Integrated Environmental Assessment and Management · doi:10.1002/ieam.4842 · Cited by 16
“Citing Boxenbaum (1982) and Dedrick (1973), USEPA noted that elimination rate constants for eight drugs in four different species were proportional to BW 0.22 and would support a similar ISF for metabolic clearance (0.78).”
BackgroundInfluentialInterspecies scaling of the pharmacokinetics of N-nitrosodimethylamine.
Gombar, C. T., Harrington, G. W., Pylypiw, H. M., Anderson, L. M., Palmer, A. E., Rice, J. M., MAGEE, P. N., & Burak, E. S. (1990) · PubMed · Cited by 15
Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins
Meibohm, B. (2019) · Springer eBooks · doi:10.1007/978-3-030-00710-2_6 · Cited by 17
Suzuki, H., Iwatsubo, T., & Sugiyama, Y. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03488-9 · Cited by 15
Prediction of ACNU plasma concentration-time profiles in humans by animal scale-up
Mitsuhashi, Y., Sugiyama, Y., Ozawa, S., Nitanai, T., Sasahara, K., Nakamura, K.-I., Tanaka, M., Nishimura, T., Inaba, M., & Kobayashi, T. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689271 · Cited by 15
“Animal scale-up is an allometric interspecies scaling technique using pharmacokinetic data [5].”
MethodSy, S. K. B., Wang, X., & Derendorf, H. (2014) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4939-1304-6_1 · Cited by 20
“Hence, a major application of PBPK model was in the field of species scaling (Boxenbaum 1982; Boxenbaum and Ronfeld 1983; Dedrick 1973; Dedrick and Bischoff 1980; Mordenti and Chappell 1989).”
BackgroundInterspecies extrapolations in risk analysis
Travis, C. C. (1987) · Toxicology · doi:10.1016/0300-483x(87)90157-0 · Cited by 14
Trends in Drug Targeting for Cancer Treatment
Singh, M. S., Ferdous, A. J., Branham, M. L., & Betageri, G. V. (1996) · Drug Delivery · doi:10.3109/10717549609029462 · Cited by 14
THE PHARMACOKINETICS OF METABOLISM OF INHALATION ANAESTHETICS: A simulation study
Feingold, A., & Holaday, D. A. (1977) · British Journal of Anaesthesia · doi:10.1093/bja/49.2.155 · Cited by 14
Campbell, B., & Ings, B. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-5950-7_7 · Cited by 13
Biologically Based Modeling in Toxicology Research
Andersen, M. E., Krishnan, K., Conolly, R. B., & McClellan, R. O. (1992) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-77260-3_29 · Cited by 13
d-Amphetamine Thermal Effects, Metabolic Rate and Motor Activity in Rats
Yehuda, S., & Kahn, M. (1977) · International Journal of Neuroscience · doi:10.3109/00207457709147211 · Cited by 13
Xiang, H., Reyes, A. E., Eppler, S., Kelley, S. K., & Damico‐Beyer, L. A. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2200-3 · Cited by 14
“The following equations, described by Dedrick and Deng and colleagues [20, 21], were used:”
MethodMonoclonal Antibodies: Interspecies Scaling With Minimal Preclinical Information
Han, C., & Zhou, H. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.1 · Cited by 12
Regulation and control in physiological systms: 1960–1980
Goodman, L. (1980) · Annals of Biomedical Engineering · doi:10.1007/bf02363432 · Cited by 12
Pierrillas, P. B., Hénin, É., Ball, K., Ogier, J., Amiel, M., Kraus‐Berthier, L., Chenel, M., Bouzom, F., & Tod, M. M. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.085605 · Cited by 12
“Other more sophisticated strategies have also been developed (Dedrick, 1973; Wajima et al., 2004), based on the assumption that E.”
BackgroundMethodInfluentialShin, B. S., Kim, D. H., Cho, C. Y., Park, S. K., Chung, S. G., Cho, E.-H., Lee, S. H., Joo, J. H., Kwon, H. S., Lee, K. C., et al. (2003) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.352 · Cited by 12
Doan, K. M. M., & Boje, K. M. K. (2000) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.242 · Cited by 13
Interspecies pharmacokinetic scaling of metazosin, a novel alpha‐adrenergic antagonist
Lapka, R., Rejholec, V., Sechser, T., Peterková, M., & Šmíd, M. (1989) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510100607 · Cited by 12
Physiologic Pharmacokinetic Modeling of Polychlorinated Biphenyls
Lutz, R. J., & Dedrick, R. L. (1987) · Environmental toxin series · doi:10.1007/978-3-642-70550-2_6 · Cited by 12
Self-citationBeyond traditional toxicology: The transformative power of PBTK modeling
Damre, A. A., & Banerjee, A. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106111 · Cited by 11
Pollet, R., Glatz, C. E., & Dyer, D. C. (1985) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01065655 · Cited by 11
“aValues are scaled ( 13 ) for a 3.3-kg turkey.”
BackgroundMethodInfluentialMayumi, K., Ohnishi, S., & Hasegawa, H. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.03.002 · Cited by 11
Tadano, G., Komano, K., Yoshida, S., Suzuki, S., Nakahara, K., Fuchino, K., Fujimoto, K., Matsuoka, E., Yamamoto, T., Asada, N., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01140 · Cited by 11
Tissue Dosimetry for Reactive Metabolites
Travis, C. C. (1990) · Risk Analysis · doi:10.1111/j.1539-6924.1990.tb01052.x · Cited by 11
Method for predicting human intestinal first-pass metabolism of UGT substrate compounds
Furukawa, T. Y., Yamano, K., Naritomi, Y., Tanaka, K., Terashita, S., & Teramura, T. (2012) · Xenobiotica · doi:10.3109/00498254.2012.680620 · Cited by 10
“The values used for Q h for rats, dogs, and monkeys were based on the reported values of 58.8, 27.0, and 43.6 mL/min/kg, respectively (Sawada, 1985).”
MethodInfluentialRhomberg, L. R. (2009) · Human and Ecological Risk Assessment An International Journal · doi:10.1080/10807030903304724 · Cited by 10
“…tend to have the same components to pharmacokinetic processes, but the pace at which the processes proceed tends to be slower in larger-bodied species in a way that is often well described by scaling the units of time by dividing by the 1/4-power of body mass (Dedrick et al. 1970; Dedrick 1973).”
BackgroundPhysiologically-Based Pharmacokinetic Modeling
Andersen, M. E. (1994) · Drug Information Journal · doi:10.1177/009286159402800131 · Cited by 10
Liang, X., & Lai, Y. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1912012 · Cited by 11
Ren, H., Sai, Y., & Chen, T. (2018) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-018-0496-4 · Cited by 12
Mahmood, I. (2001) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2001.18.2.135 · Cited by 10
Cyclopentenyl cytosine: Interspecies predictions based on rodent plasma and urine kinetics
Zaharko, D. S., Kelley, J. A., Tomaszewski, J. E., Hegedũs, L., & Hartman, N. R. (1991) · Investigational New Drugs · doi:10.1007/bf00194539 · Cited by 10
“This scaling approach has been used previously in more complicated physiological models [ 7 ,8].”
MethodPharmacokinetics and cancer chemotherapy
Bischoff, K. B. (1973) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059786 · Cited by 10
“The pharmacokinetics can be obtained for various animal species as described by Dedrick ( 34 ), and in detail for MTX by Bischoff”
BackgroundBall, R., & Schwartz, S. L. (1994) · Computers in Biology and Medicine · doi:10.1016/0010-4825(94)90023-x · Cited by 9
Application of Population Pharmacokinetics for Preclinical Safety and Efficacy Studies
Porzio, S. (2013) · Bioanalysis · doi:10.4155/bio.13.147 · Cited by 9
Burton, D. T., Cooper, K. R., Goodfellow, W. L., & Rosenblatt, D. H. (1984) · Archives of Environmental Contamination and Toxicology · doi:10.1007/bf01055928 · Cited by 9
Distribution pharmacokinetics of warfarin in the rat, a non-linear multicompartment model
KEKKI, M., Julkunen, R. J. K., & Wahlstr�m, B. (1977) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508811 · Cited by 9
Use of quantitative modelling in methylene chloride risk assessment
Rhomberg, L. R. (1995) · Toxicology · doi:10.1016/0300-483x(95)03039-i · Cited by 9
Singh, R., Moreno, M., & Stanimirovic, D. B. (2021) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-021-00691-3 · Cited by 10
Ngo, L. T., Yun, H., & Chae, J. (2023) · Pharmaceuticals · doi:10.3390/ph16050684 · Cited by 8
Ahlberg, J., Giragossian, C., Li, H., Myzithras, M., Raymond, E., Caviness, G. O., Grimaldi, C. M., Brown, S.-E., Perez, R., Yang, D., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1615345 · Cited by 8
“85 for CL (a) according to the following equations.(17,31)”
BackgroundAn allometric model for predicting blood ethanol elimination in mammals
Matsumoto, H., Minowa, Y., Nishitani, Y., & Fukui, Y. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00292-5 · Cited by 8
Microcomputer programs for physiologically-based pharmacokinetic (PB-PK) modeling
Dong, M. H. (1994) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(94)90205-4 · Cited by 8
Absorption and Distribution of Xenobiotics
Standaert, F. G. (1988) · Environmental Health Perspectives · doi:10.1289/ehp.887763 · Cited by 8
Application of population analysis to physiological pharmacokinetics
Ludden, T. M., Allerheiligen, S. R. B., & Burk, R. F. (1991) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01371012 · Cited by 8
Modern Drug Discovery and Development
Alexander, J. C., & Salazar, D. E. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373639-0.00025-x · Cited by 8
Regional pharmacokinetics III. Modelling methods
Upton, R. N., Runciman, W. B., & Mather, L. E. (1991) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510120102 · Cited by 7
Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals
Woodnutt, G., Kernutt, I., & Mizen, L. W. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.11.1826 · Cited by 7
Lin, C., Gupta, S., Loebenberg, D., & Cayen, M. N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.916-919.2000 · Cited by 7
Proposals for Improving Risk Assessment in Reproductive Toxicology
Gabrielsson, J., & Larason, K. S. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb00693.x · Cited by 7
Prediction of ftorafur disposition in rats and man by a physiologically based pharmacokinetic model
YOKO, S., YOSHIJI, T., YASUFUMI, S., MANABU, H., TERUYOSHI, M., & YUKIHIKO, U. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90174-7 · Cited by 7
Significance of binding to Na,K-ATPase in the tissue distribution of ouabain in guinea pigs.
Harashima, H., Mamiya, M., Yamazaki, M., Sugiyama, Y., Sawada, Y., Iga, T., & Hanano, M. (1992) · Pharmaceutical Research · doi:10.1023/a:1015832127969 · Cited by 7
Nonlinear Pharmacokinetics Relative to Toxicity and Use of Toxicological Data
Ramsey, J. C. (1982) · Drug Metabolism Reviews · doi:10.3109/03602538208991361 · Cited by 7
Benamara, S., Troisi, C., Gattacceca, F., Sjögren, E., Nguyen, L., & Teutonico, D. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00356 · Cited by 6
Biophysical and Biochemical Analysis of Recombinant Proteins
Arakawa, T., & Philo, J. S. (2013) · CRC Press eBooks · doi:10.3109/9781420044386-6 · Cited by 6
Monoclonal Antibodies: From Structure to Therapeutic Application
Deng, R., Li, J., Boswell, C. A., Joshi, A., & Li, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-30023-3_8 · Cited by 7
Biophysical and Biochemical Analysis of Recombinant Proteins
Arakawa, T., & Philo, J. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6486-0_2 · Cited by 6
Interspecies Pharmacokinetics. 1. Allometric Scaling of Pharmacokinetic Parameters (a Review)
Полехина, О. В., Obraztsov, N. V., Petrunin, V. A., & Vysotskaya, T. A. (2014) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-014-1124-5 · Cited by 8
Physiologically Based Pharmacokinetic Models: Applications in Carcinogenic Risk Assessment
Krewski, D. R., Withey, J. R., Ku, L. F., & Travis, C. C. (1991) · Springer eBooks · doi:10.1007/978-1-4684-8053-5_20 · Cited by 6
Pharmacokinetics and Pharmacodynamics of Therapeutic Proteins and Nucleic Acids
Meibohm, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-30023-3_6 · Cited by 5
Dose and therapy individualization in cancer chemotherapy
Hempel, G. (2019) · Handbook of analytical separations · doi:10.1016/b978-0-444-64066-6.00013-7 · Cited by 5
Systems Pharmacology and Pharmacodynamics: An Introduction
Mager, D. E., & Kimko, H. H. C. (2016) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-44534-2_1 · Cited by 8
Metadata
- Authors
- Dedrick, R. L.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Dedrick, Robert L.
- Venue
- Journal of Pharmacokinetics and Biopharmaceutics
- Published
- 1973-10
- Volume
- 1
- Issue
- 5
- Pages
- 435-461
- ISSN
- 0090-466X (ISSN-L)
- OpenAlex
- W2042365192
- Cited by
- 397
- References
- 52
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 11 · 2018: 7 · 2017: 2 · 2016: 8 · 2015: 6 · 2014: 5 · 2013: 15 · 2012: 14
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Pharmacokinetics and Biopharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- drug distribution, blood flow, tissue binding, renal clearance, drug metabolism, species differences, methotrexate, thiopental, cytarabine
- MeSH terms
- Animals, Biological Transport, Biotransformation, Body Weight, Chlorides, Cytarabine, Dialysis, Diffusion, Pharmaceutical Preparations, Humans, Kinetics, Mammals, Methotrexate, Models, Biological, Organ Specificity, Pharmacology, Species Specificity, Thermodynamics, Thiopental, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.